Guanidine (guanidine) is a small molecule pharmaceutical. Guanidine was first approved as Guanidine on 1982-01-01. It is used to treat lambert-eaton myasthenic syndrome and muscle weakness in the USA. It is known to target acid-sensing ion channel 3 and nitric oxide synthase, inducible.
|Indication||lambert-eaton myasthenic syndrome, muscle weakness|
|Drug Class||Antihypertensives (guanidine derivatives)|